ArticleHaematologica2025
Characteristics and outcomes associated with CD2 and CD25 expression on bone marrow mast cells in patients with systemic mastocytosis.
Abstract read
In one paragraph
Article in Haematologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Mast cell burden and immunophenotype of Chinese patients with cutaneous mastocytosis: a 10-year study with focus on the easily neglected pathogenic features.Frontiers in medicine · 2026Article
- Case Report: aleukemic mast cell leukemia withFrontiers in oncology · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
62 authors.
Julien RossignolCEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.
Sophie Georgin-LavialleDepartment of Internal Medicine, Tenon Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Sorbonne Université, Paris.
Danielle CanioniCEREMAST, Department of Pathology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris.
Omer BeganovicUniversité Paris Cité, INSERM UMR-S1151, CNRS UMR-S8253, Institut Necker Enfants Malades, F-75015 Paris, France; Hôpital Necker Enfants-Malades, Laboratoire d'Onco-Hématologie, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris.
Chantal BrouzesUniversité Paris Cité, INSERM UMR-S1151, CNRS UMR-S8253, Institut Necker Enfants Malades, F-75015 Paris, France; Hôpital Necker Enfants-Malades, Laboratoire d'Onco-Hématologie, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris.
Olivier FainDepartment of Internal Medicine, Sorbonne University, Saint-Antoine Hospital, AP-HP, Paris.
Maël HeibligCEREMAST, Department of Hematology, Lyon-Sud Hospital, Hospices Civils de Lyon, Pierre-Bénite.
Clément GourguechonDepartment of Hematology, Amiens University Hospital, Amiens.
Philippe GuilpainCEREMAST, Department of Internal Medicine-Multi-organ Diseases, Saint-Eloi University Hospital, Montpellier University, Montpellier.
Cristina Bulai-LivideanuCEREMAST, Department of Dermatology, Hôpital Larrey, CHU Toulouse, Toulouse.
Stéphane BareteCEREMAST, Dermatology Department, Pitié-Salpêtrière Hospital, AP-HP, Paris.
Julie AgopianCentre de Recherche en Cancérologie de Marseille, INSERM U1068, Marseille.
Fabienne BrenetCentre de Recherche en Cancérologie de Marseille, INSERM U1068, Marseille.
Patrice DubreuilCentre de Recherche en Cancérologie de Marseille, INSERM U1068, Marseille.
Richard LemalCEREMAST, Adult Clinical Hematology, CHU Clermont-Ferrand, INSERM CIC501, EA 7453 - Clermont Auvergne University, Clermont-Ferrand.
Olivier TournilhacCEREMAST, Adult Clinical Hematology, CHU Clermont-Ferrand, INSERM CIC501, EA 7453 - Clermont Auvergne University, Clermont-Ferrand.
Louis TerriouCEREMAST, Department of Internal Medicine and Clinical Immunology, Claude Huriez hospital, CHRU Lille, Lille.
David LaunayCEREMAST, Department of Internal Medicine and Clinical Immunology, Claude Huriez hospital, CHRU Lille, Lille, France; Lille University, INSERM U995 LIRIC, CHU Lille, and Referral Center for Rare Systemic Autoimmune Diseases North and North-West of France, Lille.
Laurence BouilletCEREMAST, Clinical Immunology/Internal Medicine Department, National Reference Center for Angioedema, Grenoble University Hospital, Grenoble.
Catharina ChatainCEREMAST, Clinical Immunology/Internal Medicine Department, National Reference Center for Angioedema, Grenoble University Hospital, Grenoble.
Ghandi DamajCEREMAST, Hematology Institute, Normandy University School of Medicine, Caen.
Thomas BallulCEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.
Celine GrecoCEREMAST, Department of Pain and Palliative Care Unit, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris.
Laura PolivkaCEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris, France; Department of Dermatology, Reference Center for Genodermatoses (MAGEC), AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.
Laurent FrenzelCEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.
Cécile MeniCEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.
Hassiba BouktitCEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.
Dina BenabouCEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.
Clotilde DevinCEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.
Caroline Gaudy-MarquesteCEREMAST, Department of Dermatology, Aix-Marseille University, CHU Timone, Marseille.
Marie GousseffDepartment of Internal Medicine, Centre Hospitalier Bretagne Atlantique, Vannes.
Edwige Le MouelCEREMAST, Department of Internal Medicine and Clinical Immunology, Rennes University Hospital, Rennes.
Antoine NeelCEREMAST, Department of Internal Medicine, Hôtel-Dieu University Hospital, Nantes.
Dana RantaDepartment of Hematology, Nancy University Hospital, Nancy.
Roland JaussaudDepartment of Internal Medicine and Clinical Immunology, Vandoeuvre-lès-Nancy.
Thierry Jo MolinaCEREMAST, Department of Pathology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris.
Julie BruneauCEREMAST, Department of Pathology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris.
Rose-Marie JavierCEREMAST, Department of Rheumatology, Strasbourg University Hospital, Strasbourg.
Fabien PelletierCEREMAST, Department of Dermatology, Allergology Unit, University Hospital of Besançon, Besançon.
Florence CastelainCEREMAST, Department of Dermatology, Allergology Unit, University Hospital of Besançon, Besançon.
Frederique RetornazUnité de soins et de recherche en médecine interne et maladies infectieuses, European hospital, Marseille.
Quentin CabreraDepartment of Hematology, Sud Reunion University Hospital, Saint Pierre, La Réunion.
Patricia ZunicDepartment of Hematology, Sud Reunion University Hospital, Saint Pierre, La Réunion.
Marie Pierre GourinCEREMAST, Department of Hematology, CHU Dupuytren, Limoges.
Ewa Wierzbicka-HainautCEREMAST, Department of Dermatology, CHU de Poitiers, Poitiers.
Jean François ViallardDepartment of Internal Medicine and Infectious Diseases, Haut-Lévêque Hospital, CHRU Bordeaux; Bordeaux University, Bordeaux.
Christian LavigneCEREMAST, Department of Internal Medicine and Clinical Immunology, University Hospital, Angers.
Cyrille HoarauCEREMAST, Department of Clinical Immunology and Allergology, CHRU Tours, Tours.
Isabelle DurieuCEREMAST, Department of Internal Medicine, Adult Cystic Fibrosis Care Center, Hospices Civils de Lyon, Lyon.
Sophie Dimicoli-SalazarDepartment of Hematology, CHU Bordeaux, Bordeaux.
Jose Miguel Torregrosa-DiazDepartment of Hematology, CHU Poitiers, Poitiers.
Audrey DuvalParis Centre University, Imagine Institute, Data Science Platform, INSERM UMR 1163, F-75015, Paris.
Nicolas GarcelonParis Centre University, Imagine Institute, Data Science Platform, INSERM UMR 1163, F-75015, Paris.
Jeremie LespinasseeXYSTAT, Malakoff.
Angèle SoriaCEREMAST, Department of Dermatology and Allergy, Tenon Hospital, Sorbonne University, Paris.
Yannick ChantranCEREMAST, Department of Biological Immunology, Saint-Antoine Hospital, Sorbonne University, Paris.
Michel ArockCEREMAST, Laboratory of Hematology, Pitié-Salpêtrière Hospital, AP-HP, Paris Sorbonne University.
Christine BodemerCEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris, France; Department of Dermatology, Reference Center for Genodermatoses (MAGEC), AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.
Olivier LortholaryCEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.
Vahid AsnafiUniversité Paris Cité, INSERM UMR-S1151, CNRS UMR-S8253, Institut Necker Enfants Malades, F-75015 Paris, France; Hôpital Necker Enfants-Malades, Laboratoire d'Onco-Hématologie, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris.
Olivier HermineCEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris.
Ludovic LhermitteUniversité Paris Cité, INSERM UMR-S1151, CNRS UMR-S8253, Institut Necker Enfants Malades, F-75015 Paris, France; Hôpital Necker Enfants-Malades, Laboratoire d'Onco-Hématologie, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris. ludovic.lhermitte@aphp.fr.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.